SERPINA11抗体

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P12159(SERPINA11 Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

SERPINA11. a member of the serpin (serine protease inhibitor) superfamily, is a protein encoded by the SERPINA11 gene. This gene belongs to the SERPIN clade A, which includes key regulators of proteolytic processes in inflammation, coagulation, and cellular homeostasis. SERPINA11 is primarily expressed in the liver, reproductive tissues, and certain epithelial cells, though its precise physiological role remains under investigation. Structurally, it shares the conserved serpin fold, characterized by three β-sheets and a reactive center loop (RCL) that mediates protease inhibition.

Emerging studies suggest SERPINA11 may modulate extracellular matrix remodeling and inflammatory responses by inhibiting target proteases, though its specific targets are not yet fully defined. Dysregulation of SERPINA11 has been implicated in pathological conditions, including male infertility, chronic liver diseases, and cancers such as prostate and ovarian carcinomas. Its potential role in tumor progression, possibly via protease-dependent pathways or immune modulation, is an active area of research.

SERPINA11 antibodies are critical tools for detecting protein expression, localization, and functional studies. They enable applications like Western blotting, immunohistochemistry, and ELISA, aiding in biomarker discovery and mechanistic research. Commercial antibodies often target epitopes within the RCL or conserved serpin domains. However, challenges persist in ensuring antibody specificity due to high homology among serpin family members. Validated SERPINA11 antibodies hold promise for advancing diagnostic and therapeutic strategies in diseases linked to its dysfunction. Ongoing research aims to clarify its biological interactions and therapeutic potential.